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Abstract: We evaluated a GnRH contraceptive vaccine in penned feral swine that were captured 
throughout Florida. In March 2002, pigs (~7-30kg) were segregated by sex and assigned to two 
GnRH treatments, given as a single IM injection in the rump using AdjuVac adjuvant. Ten males 
and 9 females received 1000µg GnRH-KLH; 10 males and 9 females received 2000µg GnRH-
KLH. Untreated males and females served as controls. In mid-June 2002, blood was taken and 
males and females were combined into two large breeding pens. Animals were euthanized in 
December and blood and tissue samples were taken. Reduced testicular and ovarian size, and 
serum testosterone and progesterone were evident in GnRH-treated animals and corresponded to 
increased antibody titers to GnRH.  The most effective GnRH vaccine dose for females was 
2000µg; for males it was 1000µg. The 2000µg GnRH vaccine prevented pregnancy in 100% of 
the females at slaughter and 90% of the females during the 36-week study. For females receiving 
the 1000µg GnRH vaccine, 78% were not pregnant at slaughter, but only 44% were not pregnant 
during the entire study. We conclude that the single-shot GnRH vaccine is highly effective for 
contraception of feral female swine for up to 36 weeks. 
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INTRODUCTION 
Overpopulation of feral swine raises 
concerns relating to damage of wild 
ecosystems and agricultural crop damage. 
Rooting and feeding behaviors can cause 
considerable damage to native vegetation as 
well as to forest plantings, row crops and 
pastures.  Feral swine are also  recognized as  
 
 
disease reservoirs for brucellosis and 
pseudorabies among other diseases, and 
increase the risk of disease spread to other 
wildlife, domestic livestock and humans.  
Population reduction using contra-ceptives 
has the potential to minimize these concerns 
providing that their safety and efficacy is 
demonstrated. Immunocontraceptive 
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vaccines meeting these criteria, and of 
interest for wildlife population control, are 
those that target the zona pellucida of the 
ovum or the hypothalamic peptide, 
gonadotropin releasing hormone (GnRH). 
Although the porcine zona pellucida vaccine 
has been shown to be effective for 
contraception of several wildlife species 
(Fagerstone et al. 2002), its use for swine is 
problematic because the vaccine is prepared 
using porcine zona pellucida protein, 
making it less immunogenic.  
The GnRH vaccine has been studied 
in domestic and farm animals for potential 
as a non-surgical castrating agent, and in 
swine to eliminate boar taint (Dunshea et al. 
2001).  In short duration studies GnRH 
vaccines have been evaluated as 
immunocastration agents in cattle (Adams 
and Adams 1992), horses (Rabb et al. 1990), 
and swine (Meloen et al. 1994, Oonk et al. 
1998, Zeng et al. 2002).  Recently, we 
completed a long-term study using a GnRH 
vaccine on white-tailed deer establishing its 
efficacy, safety and reversibility (Miller et 
al. 2000). The objectives of the present 
study were to evaluate the effects of a 
single-shot GnRH vaccine on reproductive 
physiology and contraception of male and 
female feral swine (Sus scrofa). 
 
MATERIALS AND METHODS 
 The study was conducted on a farm 
near Gainesville, FL. The site was a wooded 
area that included several outdoor pens to 
confine the feral swine. Wild pigs of 
unknown history were captured throughout 
Florida from January-March 2002 and 
brought to the study site for preliminary 
testing. Although no body weights were 
taken, estimates ranged from 7-32 kg. Some 
pigs were obviously pregnant, most were 
sexually mature, but some were immature at 
the start of the study. Initially, pigs were 
dewormed, tested for brucellosis and 
pseudorabies and positive reactors were 
eliminated.   
 The GnRH vaccine was developed at 
the National Wildlife Research Center and 
has been used previously in white-tailed 
deer (Miller et al. 2000). A synthetic peptide 
of GnRH was conjugated to KLH and 
combined with AdjuVac adjuvant to prepare 
1 ml vaccination doses. 
 Pigs were segregated by sex and 
randomly assigned to two GnRH treatments, 
given as a single IM injection in the rump. 
Ten males and 9 females received 1000µg 
GnRH-KLH; 10 males and 9 females 
received 2000µg GnRH-KLH. Five males 
and 5 females served as untreated controls. 
On March 21, 2002, blood samples were 
taken and pigs immunized. Males and 
females were segregated and also sorted into 
pens by large and small size. In mid-June 
2002, approximately 12 weeks after 
immunization, blood samples were taken 
and males and females were combined into 
two large breeding pens. Observations made 
throughout the study indicated some 
mounting and breeding activity. Females 
having litters during the 36-week study were 
recorded, as were those females that were 
pregnant at slaughter.  
During the second week of 
December 2002, pigs were euthanized and 
blood and tissue samples were taken. 
Reproductive tracts were excised, and testes 
and ovaries were weighed. Pregnancy status 
of females was recorded.  Blood serum 
samples were assayed for antibody titers and 
progesterone or testosterone concentrations 
as previously described (Miller and Killian 
2001).   
 
RESULTS 
Females given the 2000µg GnRH 
vaccine produced somewhat higher titers 
than those give the 1000µg GnRH dose 12 
weeks after vaccination (Figure 1a) but the 
2000µg dose was clearly more effective in 
 130
sustaining the antibody titer 36 weeks post-
vaccination than the 1000µg dose. In 
contrast, the 1000µg GnRH vaccine in males 
was more effective in producing antibody 
titers at both 12 and 36 weeks than the 
2000µg dose (Figure 1b). 
 
Figure 1a. Average serum antibody titers 
(x10000) of female feral swine determined 
in March at immunization and in June 
and December, 12 and 36 weeks post-
immunization for females receiving 
1000µg or 2000µg GnRH-KLH 
vaccinations. 
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Figure 1b. Average serum antibody titers 
(x10000) of male feral swine determined 
in March at immunization and in June 
and December, 12 and 36 weeks post-
immunization for males receiving 1000µg 
or 2000µg GnRH-KLH vaccinations. 
 MaleTiters
0
20
40
60
80
100
120
140
March June December
Sample Date
A
nt
i-G
nR
H
 ti
te
r 
X
 1
00
0
1000ugM
2000ugM
 
 
In females, average serum 
progesterone of treated animals was similar 
to controls at 12 weeks post immunization, 
but was lower than controls at 36 weeks in 
both 1000µg and 2000µg GnRH vaccine-
treated females than in controls (Figure 2a). 
In males, average serum testosterone was 
less in treated males than controls at both 12 
and 36 weeks (Figure 2b). 
 
Figure 2a. Average serum progesterone 
concentrations of female feral swine 
receiving 1000µg or 2000µg GnRH-KLH 
vaccinations. Determinations were made 
for the initial sample in March and for 
samples obtained in June and December, 
12 and 36 weeks post-immunization. 
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Figure 2b. Average serum testosterone 
concentrations of male feral swine 
receiving 1000µg or 2000µg GnRH-KLH 
vaccinations. Determinations were made 
for the initial sample in March and for 
samples obtained in June and December, 
12 and 36 weeks post-immunization.  
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At slaughter, reproductive tracts 
were regressed and inactive in most of the 
GnRH vaccinated females, but never in the 
female controls. Regressed reproductive 
tracts appeared similar to those of pre-
pubertal animals. Fully regressed testes were 
occasionally seen in the treated males, but 
intermediate stages of regression were the 
most commonly observed in the treated 
male. Average weight of both ovaries at 
slaughter was similar for treated females, 
and less than controls (Figure 3a). Average 
weight of the testes was only less than the 
controls in males receiving the 1000µg 
GnRH vaccine dose (Figure 3b), which 
corresponded to the higher antibody titers in 
male seen with this dose (Figure 1b).  
 
Figure 3a. Average weight of both ovaries 
recovered from feral swine receiving 
1000µg or 2000µg GnRH vaccine 
treatments or untreated controls. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3b. Average weight of both testes 
recovered from feral swine receiving 
1000µg or 2000µg GnRH vaccine 
treatments or untreated controls. 
 
 
 
 
 
 
 
 
 
The ability of the GnRH vaccine to 
prevent pregnancy and farrowing prior to 
slaughter was evaluated by recording 
females who had litters during the 36-week 
study. Some of these females were pregnant 
at the start of the study based on their 
farrowing dates, whereas others became 
pregnant during the study. For purposes of 
treatment analysis, these observations are 
summarized as the percent females not 
pregnant during the entire study and the 
percent not pregnant at slaughter (Figure 4). 
As expected, all of the controls were 
pregnant during the study and at slaughter. 
The 2000µg GnRH vaccine was most 
effective in preventing pregnancy, with 
100% of the females not pregnant at 
slaughter and 90% not pregnant during the 
36-week study. Of the females receiving the 
1000µg GnRH vaccine, 78% were not 
pregnant at slaughter, but only 44% were not 
pregnant during the entire study. 
 
Figure 4.  Percent females not pregnant 
during the entire study and the percent 
not pregnant at slaughter for feral swine 
treated with 1000µg or 2000µg GnRH 
vaccine, or for treated controls. 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
The present study demonstrated that 
the GnRH vaccine was effective in 
generating antibody titers in both male and 
female feral swine that altered several 
aspects of reproductive physiology.  These 
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effects included reduced ovary and testis 
weight, reduced plasma testosterone and 
progesterone concentrations, and reduced 
pregnancy rates in treated pigs compared to 
controls. The believed mechanism of action 
of the anti-GnRH titers produced by the 
vaccine is to inactivate GnRH from the 
hypothalamus, and thereby block the normal 
stimulation of gonadotropic hormones which 
regulate reproductive steroid and gamete 
production by the testes and ovaries (Miller 
et al. 2000). The effects we observed in the 
treated pigs in the present study are 
consistent with this mechanism of action. 
In the context of contraception of 
feral swine, the most impressive results were 
obtained with the single-shot 2000µg GnRH 
vaccine give to the females. None of the 
females in this group were pregnant at 
slaughter and only one of the females 
farrowed during the study. Because she 
farrowed in late November, we estimate she 
conceived in early August. Most of the 
females in the 2000µg group had 
reproductive tracts that were clearly 
regressed and ovaries that were inactive. 
Almost 80% of the females receiving the 
1000µg GnRH vaccine were infertile at 
slaughter, whereas only about 45% remained 
infertile for the entire study.  The differences 
observed between the two treatments are 
likely related to the greater anti-GnRH titers 
present at slaughter in the females receiving 
the 2000µg vaccine. It is noteworthy that 
while titers were similar between both 
treatments 12 weeks after, the titer was 
better sustained after 36 weeks in females 
receiving the 2000µg dose. 
The physiological responses of males 
to the vaccine were generally less definitive 
than that observed for the females.  The 
experimental design did not enable us to 
specifically test the fertility of individual 
males, because control and treated males 
were commingled with females. However, 
based on testicular weights taken at 
slaughter and serum testosterone values, we 
are able to make some inferences about the 
treatment effects on the males. Serum 
testosterone was clearly less in both groups 
of treated males than in controls. 
Interestingly, reduction in testicular weight 
compared to the controls was greatest in 
males receiving the 1000µg treatment. This 
is likely associated with higher anti-GnRH 
titers in the 1000µg vaccine-treated males 
throughout the study than those receiving 
the 2000µg dose.  
An unexpected finding was that the 
optimal dose for the maximal negative effect 
on reproductive physiology was the 1000µg 
dose for males and 2000µg for females. It is 
difficult to know why these gender 
differences exist, but it may be related to 
cyclic hormone secretion patterns associated 
with females, but not males. Furthermore, 
without histochemical analyses of the male 
reproductive tissues we do not know the 
extent to which spermatogenesis may have 
been disrupted as a result of the treatment.  
In conclusion, these studies have 
demonstrated that the single-shot GnRH 
vaccine was highly effective in reducing 
fertility of females during the 36-week 
study. The vaccine also negatively impacted 
testis weight and serum testosterone. These 
observations are significant in that most 
prior studies using GnRH vaccines require 
booster vaccinations to produce antibody 
titers sufficient to impair reproductive 
physiology. Remaining questions to be 
addressed in future studies are the duration 
of infertility, the reversibility of the effects, 
and whether an oral form of this vaccine can 
be developed for field applications. 
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